Introduction of Regulatory Affairs

50 %
50 %
Information about Introduction of Regulatory Affairs
Education

Published on April 2, 2013

Author: girishswami

Source: authorstream.com

PowerPoint Presentation: Girish Swami, (M.Pharm, PGDIPR, PGDDRA) International Regulatory Affairs Dept. +91-9881492626 pr.girish@gmail.com Introduction of Regulatory Affairs Regulatory Affairs: Regulatory Affairs Role of RA: Role of RA To keep track of the ever-changing legislation Registration documents to regulatory agencies To give strategic and technical advice to R&D, Production, QC dept etc. You should know: You should know What is Dossier ? What is DMF ? What is CTD / eCTD ? What is NDA / ANDA and MAA ? What is Dossier ?: What is Dossier ? Dossier is a collection or file of documents that contains all the technical data of pharmaceutical product to be approved / registered / marketed in a country. It most commonly called as Registration Dossier , In US : New Drug Application (NDA), In EU : Marketing Authorization Application (MAA) What is DMF ? Drug Master File (DMF): What is DMF ? Drug Master File (DMF) US U nited S tate D rug M aster F ile ( US-DMF ) EU E uropean D rug M aster F ile ( EDMF ) or A ctive S ubstance M aster F ile ( ASMF ) Type I – Mfg. Site, Facilities, Operating Procedures, and Personnel (no longer applicable) Type II - DS, Intermediate & Material Used in Their Preparation or Drug Product Type III - Packaging Material Type IV - Excipient, Colorant, Flavor or Material Used in Their Preparation Type V - FDA Accepted Reference Information (FDA discourages its use) [ Applicant’s Part / Open Part and Restricted part / Closed part ] What is CTD/eCTD ?: What is CTD/eCTD ? C ommon T echnical D ocument ( CTD ): Its an format set by ICH which was agreed by the Regulatory Agencies of Europe , Japan & the US . Its electronic version called as e lectronic C ommon T echnical D ocument ( eCTD ). The CTD Triangle: The CTD Triangle CTD Modules: CTD Modules Module 1 – Administrative Information (Region Specific) Module 2 – CTD Summaries (QOS) Module 3 – Quality (CMC) Module 4 – Non-Clinical Study Reports Module 5 – Clinical Study Reports Module 1 Administrative Information (Region Specific): Module 1 Administrative Information (Region Specific) For USA Application form 356h Proposed label Patent certification / information Debarment certificate Letter of Authorization (LoA)/ DMF letter Labeling text For EU Application form Summary of product characteristics Labelling text and mock-ups Information about the experts Environmental risk assessment Description of the pharmacovigilance system Risk management plan Should contain documents specific to each region Module 2 CTD Summaries (QOS): Module 2 CTD Summaries (QOS) It contain 7 sections in the following order: 2.1 CTD TOC (Module 2-5) 2.2 CTD Introduction 2.3 Quality Overall Summary 2.4 Non-clinical Overview 2.5 Clinical Overview 2.6 Non-Clinical Summary 2.7 Clinical Summary Module 3 Quality (CMC): Module 3 Quality (CMC) 3.1 TOC of Module 3 3.2 Body of Data 3.2.S - Drug substance 3.2.P - Drug product 3.2.A - Appendices 3.2.R - Regional Information 3.3 Literature references Module 4 Non-Clinical Study Reports: Module 4 Non-Clinical Study Reports 4.1 TOC of Module 4 4.2 Study reports 4.2.1 Pharmacology 4.2.2 Pharmacokinetics 4.2.3 Toxicology 4.3 Literature References Module 5 Clinical Study Reports: Module 5 Clinical Study Reports 5.1 TOC of Module 5 5.2 Tabular listing of Clinical Studies 5.3 Clinical study reports 5.3.1 Reports of Biopharmaceutical (BA-BE) Study 5.3.2 Reports of Pharmacokinetic ( biomaterial ) study 5.3.3 Reports of Pharmacokinetic (PK) Studies 5.3.4 Reports of Pharmacodynamic (PD) Studies 5.3.5 Reports of Efficacy and Safety studies 5.3.6 Reports of Post-Marketing experience 5.3.7 Case Report Forms & Individual patient listings 5.4 Literature References eCTD: eCTD Its electronic version of CTD, so called as e lectronic C ommon T echnical D ocument ( eCTD ). eCTD composed of two types of specification Content specification – As defined by ICH Technical specification – Electronic software's PowerPoint Presentation: eCTD is highly recommended by USFDA for NDAs, BLAs, DMFs and INDs filing From year 2010 European Union also make compulsory for electronic CTD submission to all procedures eCTD Characteristics: eCTD Characteristics Structure All Modules 1 to 5 have granularity options. PDF documents linked via XML backbone Increased document granularity. Transparency of entire submission Ease of navigation and review eCTD Template: eCTD Template M1: M1 M2: M2 M3: M3 M4: M4 M5: M5 Benefits of eCTD: Benefits of eCTD

Add a comment

Related presentations

Related pages

Introduction to Regulatory Affairs in the EU | RAPS

Introduction to Regulatory Affairs in the EU. This course focuses on the development of healthcare product regulation in the EU. It discusses the ...
Read more

Introduction to Regulatory Affairs by Aarti Chandak

A regulatory affair is a profession which protects the public health by controlling the safety and efficacy of products such as pharmaceuticals, medical ...
Read more

Fundamentals of European Regulatory Affairs

Understanding Medicine Registration Requirements and ... a grounding knowledge of regulatory affairs in ... Introduction to Regulatory Affairs in the ...
Read more

Introduction to Regulatory Affairs US and Canada | RAPS

Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland ...
Read more

Introductory Courses in Regulatory Affairs - home | TOPRA

Intensive introductory residential course to build a solid foundation in regulatory affairs
Read more

Introduction to Regulatory affairs, free online course by NIH

Author Topic: Introduction to Regulatory affairs, free online course by NIH (Read 11945 times)
Read more

Pharmaceutical Regulatory Affairs: An introduction

pharmaceutical regulatory services: introduction . role of a pharmaceutical regulatory services professional . pharmaceutical regulatory affairs: introduction
Read more